TACKoMesh: Comparison of Mesh Fixation Techniques in Elective Laparoscopic Repair of Incisional Hernia - ReliaTack™ v ProTack™

Sponsor
Manchester University NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT03434301
Collaborator
Medtronic (Industry)
63
1
2
38.1
1.7

Study Details

Study Description

Brief Summary

This study is designed to examine the effects on post operative pain after the use of a fixation device to secure a mesh in the abdomen to repair a hernia of the abdominal wall. The fixation devices to be used differ with one being made from titanium and is permanent and the other being made from an absorbable material. Both fixation devices are commonly used but two questions remain unanswered, does one cause more chronic pain and also what if any will be the effect on recurrence rates of the hernia. No trial has been undertaken to date which will not only examine the fixation device but in the setting where the hernia is closed first. The closure of the hernial defect by the keyhole technique is a relatively new and growing concept in the hernia world.

Condition or Disease Intervention/Treatment Phase
  • Device: ReliaTack™
  • Device: Protack™
N/A

Detailed Description

TACKoMESH study (Comparison of using absorbable tacks (ReliaTack™) against a non-absorbable tack (Protack™) to fixate Symbotex™ composite mesh in the elective repair of incisional hernia) is a prospective, single-centre, double blinded randomised trial which aims to establish whether the use of absorbable (ABS) compared to non-absorbable (Non-ABS) tacks in adult patients undergoing elective incisional hernia repair produces a lower rate of pain both immediately and long-term. Secondary outcomes to be explored include seroma formation, hernia recurrence, length of postoperative hospital stay, wound infection, reoperation rate, operation time, health related quality of life and time to return to normal daily activity.

Patients entering TACKoMesh will be randomised immediately prior to their operation with a 1:1 ratio of ABS versus Non-ABS tack arm allocation. The same composite mesh will be used for all operations. Follow-up is according to a predetermined schedule, using specifically designed Case Report Forms to collect the blinded data.

Study Design

Study Type:
Interventional
Actual Enrollment :
63 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
Comparison of Mesh Fixation Techniques in Elective Laparoscopic Repair of Incisional Hernia - ReliaTack™ v ProTack™ (TACKoMesh Study)
Actual Study Start Date :
Jul 20, 2017
Actual Primary Completion Date :
Sep 22, 2020
Actual Study Completion Date :
Sep 22, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Mesh with absorbable tack fixation

Mesh with absorbable tack (ReliaTack™) fixation

Device: ReliaTack™
Absorbable tack (ReliaTack™) to fixate Symbotex™ composite mesh in the elective repair of incisional hernia.

Active Comparator: Mesh with non-absorbable fixation

Mesh with non-absorbable (Protack™) fixation

Device: Protack™
Non-absorbable tack (Protack™) to fixate Symbotex™ composite mesh in the elective repair of incisional hernia.

Outcome Measures

Primary Outcome Measures

  1. Pain score [30 days]

    Pain Score at rest and activity at day 30 recorded using visual analogue pain score (VAS) (0-10cm).

Secondary Outcome Measures

  1. Visual analogue pain score (VAS). [Day 1, days 5-7, 3 months, 1 year.]

    Visual analogue pain score (VAS) pain score at days 1, 5-7 3 months and 1 year post-operative. A preoperative VAS score will also be recorded.

  2. Seroma formation. [Days 1, 6, 30, 3 months and 1 year post-operation.]

    Seroma formation (no fixed time point) (a seroma will be defined as any clinically apparent fluid collection at the site of mesh placement).

  3. Postoperative hospital stay. [Time from end of Surgery to patient discharge (up to end of study; 104 weeks).]

    The length of postoperative hospital stay.

  4. Time to return to normal daily activity. [From day of surgery to end of study (104 weeks).]

    The time to return to normal daily activity.

  5. Wound infection. [Days 1, 6, 30, 3 months and 1 year post-operation.]

    Any wound infection.

  6. Operating time. [Length of Operation.]

    The time taken for the Operation - from start to finish.

  7. Mesh fixation time. [Time during Operation.]

    Mesh fixation time after adhesions have been taken down and fascia closed.

  8. Hernia recurrence. [Days 1, 6, 30, 3 months and 1 year post-operation.]

    Hernia recurrence at one year and at all time points.

  9. Health-related quality of life. [30 days and 1 year post-operation.]

    Health-related quality of life - assessed using the Carolinas Comfort Score™ (which is specifically designed for hernia repair) (26) and Short Form 36™, at pre-operatively, 30 days and 1 year, (appendix K and SF-36).

  10. Adverse Events. [Days 1, 6, 30, 3 months and 1 year post-operation.]

    To capture any Adverse Events during the study duration.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

• All adults undergoing elective incisional hernia repair for midline abdominal incisional hernia, with a defect of 3-10cm in diameter.

Exclusion Criteria:
  • Patients less than 18 years of age, or unable to give informed consent.

  • Patients over 80 years of age.

  • Females of reproductive age.

  • Prisoners.

  • Clinically small incisional hernia <3cm maximum diameter.

  • Emergency procedures (for irreducible, strangulated or obstructed hernia).

  • Procedure involving dirty (purulent inflammation (e.g. abscess); preoperative perforation of respiratory, gastrointestinal, biliary or genitourinary tract; penetrating trauma >4 hours old) or contaminated (Non-purulent inflammation; gross spillage from gastrointestinal tract; entry into biliary or genitourinary tract in the presence of infected bile or urine; major break in technique; penetrating trauma <4 hours old; chronic open wounds to be grafted or covered) surgery.

  • Patients with a Body Mass Index (BMI) >40 kg/m².

  • Patients participating in any other study, whose concurrent participation in the TACK study might place them at undue risk or might confound the study data in the opinion of the chief investigators.

  • Failure to close the anterior rectus sheath intraoperatively.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Manchester University NHS Foundation Trust Manchester United Kingdom M13 9WL

Sponsors and Collaborators

  • Manchester University NHS Foundation Trust
  • Medtronic

Investigators

  • Principal Investigator: Aali J Sheen, Manchester University NHS Foundation Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Manchester University NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT03434301
Other Study ID Numbers:
  • R04484
First Posted:
Feb 15, 2018
Last Update Posted:
Dec 7, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Manchester University NHS Foundation Trust
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 7, 2021